Detalhe da pesquisa
1.
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
Diabetes Metab Res Rev
; 40(3): e3787, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461408
2.
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
J Hepatol
; 79(6): 1524-1541, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730124
3.
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 21(6): 1523-1532.e1, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421583
4.
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank.
Liver Int
; 43(6): 1247-1255, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883784
5.
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Liver Int
; 43(8): 1761-1771, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088979
6.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
J Hepatol
; 77(3): 596-606, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405176
7.
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores.
Clin Gastroenterol Hepatol
; 20(3): 658-673, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091049
8.
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Gastroenterology
; 160(5): 1634-1646.e7, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347879
9.
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank.
Int J Obes (Lond)
; 46(3): 486-493, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750514
10.
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up.
Liver Int
; 42(12): 2769-2780, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166317
11.
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
Liver Int
; 42(2): 374-383, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890093
12.
Genetic variants in the MTHFR are not associated with fatty liver disease.
Liver Int
; 40(8): 1934-1940, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460399
13.
Reply.
Clin Gastroenterol Hepatol
; 21(3): 856-857, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835343
14.
Reply to: "Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank".
Liver Int
; 43(6): 1362-1364, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166135
15.
Fatty liver disease genetic risk variants and interference on sex hormones.
Liver Int
; 43(5): 958-961, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161848
16.
Reply.
Clin Gastroenterol Hepatol
; 20(11): 2660-2661, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032632
17.
Understanding the underlying molecular pathways by which Mboat7/Lpiat1 depletion induces hepatic steatosis.
J Lipid Res
; 62: 100047, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582144
18.
Machine learning reveals the contribution of lipoproteins to liver triglyceride content and inflammation.
J Clin Endocrinol Metab
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833012
19.
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
Aliment Pharmacol Ther
; 59(11): 1402-1412, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497224
20.
Predictors of controlled attenuation parameter in metabolic dysfunction.
United European Gastroenterol J
; 12(3): 364-373, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141028